• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓基质细胞衍生的白细胞介素-8通过核因子-κB转录因子上调多发性骨髓瘤细胞上脊髓灰质炎病毒受体的表达。

Bone Marrow Stromal Cell-Derived IL-8 Upregulates PVR Expression on Multiple Myeloma Cells via NF-kB Transcription Factor.

作者信息

Mekhloufi Abdelilah, Kosta Andrea, Stabile Helena, Molfetta Rosa, Zingoni Alessandra, Soriani Alessandra, Cippitelli Marco, Paolini Rossella, Gismondi Angela, Ricciardi Maria Rosaria, Petrucci Maria Teresa, Masuelli Laura, Caracciolo Giulio, Palchetti Sara, Santoni Angela, Fionda Cinzia

机构信息

Department of Molecular Medicine, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, 00161 Rome, Italy.

Division of Hematology, Department of Translational Medicine and Precision, Sapienza University of Rome, 00161 Rome, Italy.

出版信息

Cancers (Basel). 2020 Feb 13;12(2):440. doi: 10.3390/cancers12020440.

DOI:10.3390/cancers12020440
PMID:32069911
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7072437/
Abstract

Bone marrow stromal cells (BMSCs) strongly contribute to multiple myeloma (MM) progression, promoting the survival and growth of malignant plasma cells (PCs). However, the possible impact of these cells on the immune-mediated recognition of MM cells remains largely unknown. DNAM-1 activating receptor plays a prominent role in NK cell anti-MM response engaging the ligands poliovirus receptor (PVR) and nectin-2 on malignant PCs. Here, we analysed the role of MM patient-derived BMSCs in the regulation of PVR expression. We found that BMSCs enhance PVR surface expression on MM cells and promote their NK cell-mediated recognition. PVR upregulation occurs at transcriptional level and involves NF-kB transcription factor activation by BMSC-derived soluble factors. Indeed, overexpression of a dominant-negative mutant of IKBα blocked PVR upregulation. IL-8 plays a prominent role in these mechanisms since blockade of CXCR1/2 receptors as well as depletion of the cytokine via RNA interference prevents the enhancement of PVR expression by BMSC-derived conditioned medium. Interestingly, IL-8 is associated with stromal microvesicles which are also required for PVR upregulation via CXCR1/CXCR2 signaling activation. Our findings identify BMSCs as regulators of NK cell anti-MM response and contribute to define novel molecular pathways involved in the regulation of PVR expression in cancer cells.

摘要

骨髓基质细胞(BMSCs)对多发性骨髓瘤(MM)的进展有很大影响,可促进恶性浆细胞(PCs)的存活和生长。然而,这些细胞对MM细胞免疫介导识别的可能影响在很大程度上仍不清楚。DNAX辅助分子-1(DNAM-1)激活受体在NK细胞抗MM反应中起重要作用,可与恶性PCs上的配体脊髓灰质炎病毒受体(PVR)和NECTIN-2结合。在此,我们分析了MM患者来源的BMSCs在PVR表达调控中的作用。我们发现BMSCs可增强MM细胞表面PVR的表达,并促进其NK细胞介导的识别。PVR的上调发生在转录水平,涉及BMSC来源的可溶性因子对NF-κB转录因子的激活。事实上,IκBα显性负突变体的过表达可阻断PVR的上调。白细胞介素-8(IL-8)在这些机制中起重要作用,因为阻断CXCR1/2受体以及通过RNA干扰去除细胞因子可阻止BMSC来源的条件培养基增强PVR的表达。有趣的是,IL-8与基质微泡有关,基质微泡也是通过CXCR1/CXCR2信号激活上调PVR所必需的。我们的研究结果确定BMSCs是NK细胞抗MM反应的调节因子,并有助于确定参与癌细胞中PVR表达调控的新分子途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e37/7072437/a28227bd1259/cancers-12-00440-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e37/7072437/5cbc9037ef12/cancers-12-00440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e37/7072437/fe93ef2b23fc/cancers-12-00440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e37/7072437/d61160a31c23/cancers-12-00440-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e37/7072437/13e60dc394b5/cancers-12-00440-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e37/7072437/ba876b326a52/cancers-12-00440-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e37/7072437/cfb90d25b1d0/cancers-12-00440-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e37/7072437/a28227bd1259/cancers-12-00440-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e37/7072437/5cbc9037ef12/cancers-12-00440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e37/7072437/fe93ef2b23fc/cancers-12-00440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e37/7072437/d61160a31c23/cancers-12-00440-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e37/7072437/13e60dc394b5/cancers-12-00440-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e37/7072437/ba876b326a52/cancers-12-00440-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e37/7072437/cfb90d25b1d0/cancers-12-00440-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e37/7072437/a28227bd1259/cancers-12-00440-g007.jpg

相似文献

1
Bone Marrow Stromal Cell-Derived IL-8 Upregulates PVR Expression on Multiple Myeloma Cells via NF-kB Transcription Factor.骨髓基质细胞衍生的白细胞介素-8通过核因子-κB转录因子上调多发性骨髓瘤细胞上脊髓灰质炎病毒受体的表达。
Cancers (Basel). 2020 Feb 13;12(2):440. doi: 10.3390/cancers12020440.
2
The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.自然杀伤细胞介导的骨髓瘤细胞杀伤中对DNAX辅助分子-1(DNAM-1)、自然杀伤细胞激活受体2D(NKG2D)和自然杀伤细胞p46受体(NKp46)的需求。
Cancer Res. 2007 Sep 15;67(18):8444-9. doi: 10.1158/0008-5472.CAN-06-4230.
3
Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.B细胞活化因子在人多发性骨髓瘤细胞于骨髓微环境中的黏附和生长中的作用
Cancer Res. 2006 Jul 1;66(13):6675-82. doi: 10.1158/0008-5472.CAN-06-0190.
4
Enhancement of Neuroblastoma NK-Cell-Mediated Lysis through NF-kB p65 Subunit-Induced Expression of FAS and PVR, the Loss of Which Is Associated with Poor Patient Outcome.通过NF-κB p65亚基诱导FAS和PVR表达增强神经母细胞瘤自然杀伤细胞介导的细胞溶解作用,FAS和PVR缺失与患者预后不良相关。
Cancers (Basel). 2021 Aug 29;13(17):4368. doi: 10.3390/cancers13174368.
5
Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation.一氧化氮供体增加多发性骨髓瘤细胞中PVR/CD155 DNAM-1配体的表达:DNA损伤反应激活的作用
BMC Cancer. 2015 Jan 22;15:17. doi: 10.1186/s12885-015-1023-5.
6
Regulation of interleukin 6 in multiple myeloma and bone marrow stromal cells.多发性骨髓瘤和骨髓基质细胞中白细胞介素6的调控
Stem Cells. 1995 Aug;13 Suppl 2:35-9.
7
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.鉴定PVR(CD155)和Nectin-2(CD112)为人DNAM-1(CD226)激活分子的细胞表面配体。
J Exp Med. 2003 Aug 18;198(4):557-67. doi: 10.1084/jem.20030788. Epub 2003 Aug 11.
8
Novel therapies targeting the myeloma cell and its bone marrow microenvironment.针对骨髓瘤细胞及其骨髓微环境的新型疗法。
Semin Oncol. 2001 Dec;28(6):607-12. doi: 10.1016/s0093-7754(01)90033-8.
9
DNAM-1 and PVR regulate monocyte migration through endothelial junctions.DNAX辅助分子-1(DNAM-1)和脊髓灰质炎病毒受体(PVR)通过内皮连接调节单核细胞迁移。
J Exp Med. 2004 May 17;199(10):1331-41. doi: 10.1084/jem.20032206. Epub 2004 May 10.
10
Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines.人骨髓瘤衍生细胞系上黏附分子的细胞表面表达及功能意义
Br J Haematol. 1994 Jul;87(3):483-93. doi: 10.1111/j.1365-2141.1994.tb08302.x.

引用本文的文献

1
CD38 restrains the activity of extracellular cGAMP in a model of multiple myeloma.在多发性骨髓瘤模型中,CD38抑制细胞外cGAMP的活性。
iScience. 2024 Apr 25;27(5):109814. doi: 10.1016/j.isci.2024.109814. eCollection 2024 May 17.
2
Natural killer cells affect the natural course, drug resistance, and prognosis of multiple myeloma.自然杀伤细胞影响多发性骨髓瘤的自然病程、耐药性及预后。
Front Cell Dev Biol. 2024 Feb 12;12:1359084. doi: 10.3389/fcell.2024.1359084. eCollection 2024.
3
Dysregulation of DNAM-1-Mediated NK Cell Anti-Cancer Responses in the Tumor Microenvironment.

本文引用的文献

1
CD155: A Multi-Functional Molecule in Tumor Progression.CD155:肿瘤进展中的多功能分子。
Int J Mol Sci. 2020 Jan 30;21(3):922. doi: 10.3390/ijms21030922.
2
The Ubiquitin-proteasome pathway regulates Nectin2/CD112 expression and impairs NK cell recognition and killing.泛素-蛋白酶体途径调节 Nectin2/CD112 的表达,并损害 NK 细胞的识别和杀伤。
Eur J Immunol. 2019 Jun;49(6):873-883. doi: 10.1002/eji.201847848. Epub 2019 Mar 27.
3
Key Role of the CD56CD16 Natural Killer Cell Subset in the Recognition and Killing of Multiple Myeloma Cells.
肿瘤微环境中DNAM-1介导的自然杀伤细胞抗癌反应失调。
Cancers (Basel). 2023 Sep 18;15(18):4616. doi: 10.3390/cancers15184616.
4
CD155 and Its Receptors as Targets for Cancer Therapy.CD155 及其受体作为癌症治疗的靶点。
Int J Mol Sci. 2023 Aug 19;24(16):12958. doi: 10.3390/ijms241612958.
5
Cross-Dressing of Multiple Myeloma Cells Mediated by Extracellular Vesicles Conveying MIC and ULBP Ligands Promotes NK Cell Killing.细胞外囊泡传递 MIC 和 ULBP 配体介导的多发性骨髓瘤细胞的交叉染色促进 NK 细胞杀伤。
Int J Mol Sci. 2023 May 30;24(11):9467. doi: 10.3390/ijms24119467.
6
Role of NF-κB Signaling in the Interplay between Multiple Myeloma and Mesenchymal Stromal Cells.NF-κB 信号在多发性骨髓瘤与间充质基质细胞相互作用中的作用。
Int J Mol Sci. 2023 Jan 17;24(3):1823. doi: 10.3390/ijms24031823.
7
A novel microRNA signature for the detection of melanoma by liquid biopsy.一种通过液体活检检测黑色素瘤的新型 microRNA 特征。
J Transl Med. 2022 Oct 15;20(1):469. doi: 10.1186/s12967-022-03668-1.
8
GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells.GAS6/TAM 信号通路调控多发性骨髓瘤细胞中 MICA 的表达。
Front Immunol. 2022 Jul 28;13:942640. doi: 10.3389/fimmu.2022.942640. eCollection 2022.
9
A Hyaluronan and Proteoglycan Link Protein 1 Matrikine: Role of Matrix Metalloproteinase 2 in Multiple Myeloma NF-κB Activation and Drug Resistance.透明质酸和蛋白聚糖连接蛋白 1 基质小肽:基质金属蛋白酶 2 在多发性骨髓瘤 NF-κB 激活和耐药中的作用。
Mol Cancer Res. 2022 Sep 2;20(9):1456-1466. doi: 10.1158/1541-7786.MCR-21-0941.
10
Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease.间充质干细胞免疫调节:心血管疾病中的一种新型干预机制
Front Cell Dev Biol. 2022 Jan 12;9:742088. doi: 10.3389/fcell.2021.742088. eCollection 2021.
CD56CD16自然杀伤细胞亚群在多发性骨髓瘤细胞识别与杀伤中的关键作用
Cancers (Basel). 2018 Nov 29;10(12):473. doi: 10.3390/cancers10120473.
4
Translating the anti-myeloma activity of Natural Killer cells into clinical application.将自然杀伤细胞的抗骨髓瘤活性转化为临床应用。
Cancer Treat Rev. 2018 Nov;70:255-264. doi: 10.1016/j.ctrv.2018.10.005. Epub 2018 Oct 10.
5
A System of Cytokines Encapsulated in ExtraCellular Vesicles.细胞外囊泡包封的细胞因子系统。
Sci Rep. 2018 Jun 12;8(1):8973. doi: 10.1038/s41598-018-27190-x.
6
The NF-κB Activating Pathways in Multiple Myeloma.多发性骨髓瘤中的NF-κB激活途径。
Biomedicines. 2018 May 16;6(2):59. doi: 10.3390/biomedicines6020059.
7
Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma.透明质酸和蛋白聚糖链接蛋白 1(HAPLN1)激活硼替佐米耐药性 NF-κB 活性并增加多发性骨髓瘤的药物耐药性。
J Biol Chem. 2018 Feb 16;293(7):2452-2465. doi: 10.1074/jbc.RA117.000667. Epub 2017 Dec 26.
8
Innate immune activating ligand SUMOylation affects tumor cell recognition by NK cells.先天免疫激活配体 SUMOylation 影响 NK 细胞对肿瘤细胞的识别。
Sci Rep. 2017 Sep 5;7(1):10445. doi: 10.1038/s41598-017-10403-0.
9
Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation.源自正常和多发性骨髓瘤骨髓间充质干细胞的微泡对骨髓瘤细胞的表型和翻译起始有不同的调节作用。
Carcinogenesis. 2017 Jul 1;38(7):708-716. doi: 10.1093/carcin/bgx045.
10
Host-related immunodeficiency in the development of multiple myeloma.多发性骨髓瘤发生过程中与宿主相关的免疫缺陷
Leuk Lymphoma. 2018 May;59(5):1127-1132. doi: 10.1080/10428194.2017.1361026. Epub 2017 Aug 9.